Patient P-01730
Synthetic patientNBL-101 · Day 103 · 25–34 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
5%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S17
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-13
- Inflammatory activity-11
- Nutritional resilience+6
- Toxicity-6
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion10.1/100
improving · -3.5 vs previous 14 d
Toxicity
Blood7.8/100
stable · -0.1 vs previous 14 d
Sleep quality
Wearable60.7/100
improving · +3.3 vs previous 14 d
Energy level
Daily log7.7/10
stable · +0.0 vs previous 14 d
Stress level
Daily log3.4/10
improving · -0.3 vs previous 14 d
Steps
Wearable8,409
stable · -234 vs previous 14 d
Adherence
Companion91.3 %
stable · -3.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 106 from the failing basin, 19 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Insoluble fibre (supports)perturbation · steering +3.5
- Daily walks resumedperturbation · steering +3.3
- Insoluble fibresupporter · GI -2.3 next day
Main detractors to watch
- Alcoholperturbation · steering -4
- Poor-sleep weekperturbation · steering -3
- Low-HRV stretchperturbation · steering -2.7
- Dietary driftperturbation · steering -2.6
- Alcoholdetractor · GI +2.3 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Insoluble fibre-2.3supporter · 59%
- Alcohol+2.3detractor · 70%
- Spicy / capsaicin-1.5no signal · 41%
- Histamine load+1.2no signal · 30%
- Dietary fat load-0.2no signal · 15%
- Simple carbohydrates0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑35
- DNADPYD *2A → slower clearance
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
- DPYD *2A heterozygousSlower drug clearance
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.9 · butyrate capacity 49/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 47 ms
- Sleep
- 7.6 h
- Steps
- 8,062
- Resting HR
- 65 bpm
Daily log: GI score 10, nutritional resilience 72, adherence 91.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.